Dissociation and antidepressant response to under-the-skin esketamine treatment

This analysis explored dissociative experiences from subcutaneous esketamine in patients with treatment-resistant depression.

• Dissociative experiences may vary based on the patient's response to antidepressant treatment.
• There is a potential association between these experiences and levels of depressive symptoms.
• The findings suggest a need for further investigation into the clinical relevance of dissociative experiences in this context.

Simplified